Yield10 Bioscience, Inc. Common Stock
YTEN
YTEN was delisted on the 15th of May, 2024.
17 hedge funds and large institutions have $15.3M invested in Yield10 Bioscience, Inc. Common Stock in 2015 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 0 closing their positions.
49% more capital invested
Capital invested by funds: $10.3M → $15.3M (+$5.03M)
13% more funds holding
Funds holding: 15 → 17 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GC
GMT Capital
Atlanta,
Georgia
|
+$192K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$32K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$32K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$32K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
-$416K |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$96K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$8K |
| 4 |
TWA
TCI Wealth Advisors
Tucson,
Arizona
|
-$3K |
YTEN Hedge Fund Activity: Q1 2015 in Review
17 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Yield10 Bioscience, Inc. Common Stock (YTEN) for Q1 2015, worth a combined $15.3M — up 49% from $10.3M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new YTEN positions and 0 closed out — a net gain of 2 holders — while 2 added to existing stakes and 2 trimmed.
The largest buyer was GMT Capital, opening a new position worth an estimated $192K. The largest seller was Oracle Investment Management, cutting an estimated $416K.
- 17 institutional investors held Yield10 Bioscience, Inc. Common Stock (YTEN) as of Q1 2015, up from 15 in Q4 2014.
- Funds reported $15.3M of Yield10 Bioscience, Inc. Common Stock stock for Q1 2015, up 49% quarter-over-quarter.
- 2 funds opened new Yield10 Bioscience, Inc. Common Stock positions in Q1 2015 and 0 closed out, a net change of +2 holders.
- The largest Yield10 Bioscience, Inc. Common Stock buyer in Q1 2015 was GMT Capital, an estimated $192K added.
- The largest Yield10 Bioscience, Inc. Common Stock seller in Q1 2015 was Oracle Investment Management, an estimated $416K sold.
Based on aggregated 13F filings for Q1 2015.